PHARMACIE BUYL
0740.599.255 · rovalta.com · 26/09/2026
PHARMACIE BUYL
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMACIE BUYL is a Private limited company incorporated in 2019. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ixelles. It employs on average 3,9 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0740.599.255
- Incorporation
- 30/12/2019
- Legal form
- Private limited company
- Registered office
- Avenue Adolphe Buyl 1
1050 Ixelles · BruxellesSee on map - Contributed capital
- 30 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 3,9 ETP
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 376,6 k € | +0.7% | 373,9 k € | +1.0% | 370,1 k € | +15.3% | 320,9 k € | -20.4% | 403 k € |
| EBITDA | 85,5 k € | -27.3% | 117,5 k € | -18.0% | 143,3 k € | -0.2% | 143,7 k € | -30.8% | 207,5 k € |
| Operating result | -13,6 k € | -137% | 36,7 k € | -41.9% | 63,1 k € | -3.0% | 65,1 k € | -52.6% | 137,3 k € |
| Net result | -24,3 k € | -205% | 23,2 k € | -46.9% | 43,7 k € | +1.5% | 43 k € | -57.2% | 100,5 k € |
| Balance sheet | |||||||||
| Equity | 37,5 k € | -39.3% | 61,8 k € | -43.6% | 109,6 k € | -55.4% | 246 k € | +21.2% | 202,9 k € |
| Total assets | 956,5 k € | -9.6% | 1,1 M € | -3.4% | 1,1 M € | +4.3% | 1,1 M € | -6.9% | 1,1 M € |
| Cash | 34,7 k € | +4.8% | 33,1 k € | -57.9% | 78,6 k € | -11.7% | 89,1 k € | -3.1% | 91,9 k € |
| Debts | 919 k € | -7.7% | 995,9 k € | +1.1% | 985,2 k € | +22.5% | 804,2 k € | -13.1% | 925,4 k € |
| Other | |||||||||
| Workforce | 3,9 ETP | +2.6% | 3,8 ETP | 0.0% | 3,8 ETP | +5.6% | 3,6 ETP | -16.3% | 4,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Other companies at this address
Avenue Adolphe Buyl 1 1050 Ixelles| Company | CBE no. |
|---|---|
PHARMA BUYL-LOUISE● Active | 0764.926.261 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 30/12/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 13 months |
| Filing date | 02/06/2026 | 12/08/2025 | 04/07/2024 | 28/06/2023 | 30/05/2022 | 20/08/2021 |
| General meeting | 07/05/2026 | 01/05/2025 | 02/05/2024 | 04/05/2023 | 05/05/2022 | 06/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 07/05/2026 | 02/06/2026 | French | |
| Abridged model | 31/12/2024 | 01/05/2025 | 12/08/2025 | French | |
| Abridged model | 31/12/2023 | 02/05/2024 | 04/07/2024 | French | |
| Abridged model | 31/12/2022 | 04/05/2023 | 28/06/2023 | French | |
| Abridged model | 31/12/2021 | 05/05/2022 | 30/05/2022 | French | |
| Abridged model | 31/12/2020 | 06/05/2021 | 20/08/2021 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-24,3 k €↓
- 2024Annual accounts 202423,2 k €↓
- 2023Annual accounts 202343,7 k €↑
- 2022Annual accounts 202243 k €↓
- 2021Annual accounts 2021100,5 k €↑
- 2020Annual accounts 202073,4 k €
- 30/12/2019IncorporationPrivate limited company